Cargando…

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch

Detalles Bibliográficos
Autores principales:	Fokkens, Wytske, Hellings, Peter, Mullol, Joaquim, Munzel, Ullrich, Bachert, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493484/ http://dx.doi.org/10.1186/2045-7022-5-S4-P33

Ejemplares similares

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity.
por: Bachert, Claus, et al.
Publicado: (2015)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

Identification of gaps in the current allergic rhinitis guidelines and how these can be filled
por: Bousquet, Jean, et al.
Publicado: (2015)

Capsaicin for Rhinitis
por: Fokkens, Wytske, et al.
Publicado: (2016)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

Nocturia: a bothersome urological symptom in the elderly
por: Shekarchi, Bahram, et al.
Publicado: (2016)

Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine
por: Mullol, Joaquim, et al.
Publicado: (2005)

PD15 - MP29-02 effectively relieves both nasal and ocular symptoms in adolescents aged 12-17 years: results from a meta-analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials
por: Valovirta, Erkka, et al.
Publicado: (2014)

Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment
por: Hoffmans, Ruth, et al.
Publicado: (2018)

Thoughts on the pathophysiology of nonallergic rhinitis
por: Fokkens, Wytske J.
Publicado: (2002)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

Diagnostic strategies in nasal congestion
por: Krouse, John, et al.
Publicado: (2010)

Measuring outcomes in allergic rhinitis: psychometric characteristics of a Spanish version of the congestion quantifier seven-item test (CQ7)
por: Valero, Antonio, et al.
Publicado: (2011)

Measuring bothersome menopausal symptoms: development and validation of the MenoScores questionnaire
por: Lund, Kamma Sundgaard, et al.
Publicado: (2018)

Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023)

Quality of life and use of medication in chronic allergic and non-allergic rhinitis patients
por: Segboer, Christine, et al.
Publicado: (2013)

Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study
por: Munjal, Sagar, et al.
Publicado: (2019)

Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013)

Deposition characteristics of a new allergic rhinitis nasal spray (MP29-02*) in an anatomical model of the human nasal cavity
por: D’Addio, Alex, et al.
Publicado: (2015)

Severity and Bothersomeness of Urinary Tract Infection Symptoms in Women before and after Menopause
por: Teglbrænder-Bjergkvist, Signe, et al.
Publicado: (2023)

Most bothersome symptom in migraine and probable migraine: A population-based study
por: Kim, Seung Jae, et al.
Publicado: (2023)

New insights into the pathogenesis of non-allergic rhinitis
por: Segboer, Christine, et al.
Publicado: (2015)

Diagnostic tools in Rhinology EAACI position paper
por: Scadding, Glenis, et al.
Publicado: (2011)

Direct and indirect costs of allergic and non‐allergic rhinitis in the Netherlands
por: Avdeeva, Klementina S., et al.
Publicado: (2020)

Patient-reported symptom distress, and most bothersome issues, before and during cancer treatment
por: Hong, Fangxin, et al.
Publicado: (2016)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Symptoms of chronic rhinosinusitis with and without nasal polyps
por: Dietz de Loos, Dirk, et al.
Publicado: (2013)

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
por: Hox, Valerie, et al.
Publicado: (2020)

Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
por: Hox, Valerie, et al.
Publicado: (2020)

Factors associated with a clinically relevant reduction in menopausal symptoms of a standardized acupuncture approach for women with bothersome menopausal symptoms
por: Waldorff, Frans Boch, et al.
Publicado: (2021)

Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management
por: Bachert, C., et al.
Publicado: (2018)

Acute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity
por: Hoffmans, Ruth, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sr28l100ih23o5bmpbqtj0oegv